Skip to content
Governance Register

← US public companies

Contrafect Corp

SEC CIK 1478069 · CRFX · last insider filing 2023-02-16

Directors (from insider filings)

NameCapacity as filedFilings
Barer SOL J Director filed 2014 - 2022
Otto Michael J. Director filed 2014 - 2022
Gilman Steven C Director · Interim CEO filed 2015 - 2022
Sucoff Cary Director filed 2014 - 2022
Low David N. Director filed 2014 - 2022
Aklog Lishan Director filed 2020 - 2022
Barlow Jane F Director filed 2021 - 2022
Pomerantz Roger Director · Chief Executive Officer filed 2014 - 2022
Blech Isaac Director filed 2014 - 2019
Ricciardi Lisa Director · Chief Operating Officer filed 2017 - 2017
Tian Lawrence Yuan Director filed 2015 - 2015
Scheinberg David A Director filed 2014 - 2015
Zan Shengda Director filed 2014 - 2015

Officers (from insider filings)

NameTitle as filedFilings
Messinger Michael VP Finance filed 2014 - 2023
Bogdanos Natalie General Counsel filed 2014 - 2022
Cassino Cara M Chief Medical Officer filed 2015 - 2022
Dong Nancy VP Finance & Administration filed 2014 - 2020
Muntner Joshua B SVP Business Development filed 2015 - 2018
Gregory Julia P CEO filed 2014 - 2016
Couto Daniel SVP Manufacturing & Facilities filed 2014 - 2016
Wittekind Michael G. Chief Scientific Officer filed 2014 - 2016
Kappel Barry J. SVP Business Development filed 2014 - 2015
Huang David B. Chief Medical Officer filed 2014 - 2014

About this record

From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.

Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.